Search Results - "Stade, Barbara"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Treatment with Pegylated Interferon α (PegIntron) for High-Risk Essential Thrombocythemia: Results of a Phase II Study by Langer, Christian, Lengfelder, Eva, Thiele, Jurgen, Kvasnika, Hans M., Pahl, Heike, Matzdorff, Axel, Stade, Barbara, Schauer, Stefanie, Gisslinger, Heinz, Dohner, Hartmut, Griesshammer, Martin

    Published in Blood (16-11-2004)
    “…In high risk Essential Thrombocythemia (ET) there is a indication for cytoreductive therapy. However, especially in younger patients long-term use of…”
    Get full text
    Journal Article
  8. 8

    De novo Expression of Intercellular-Adhesion Molecule 1 in Melanoma Correlates with Increased Risk of Metastasis by Johnson, Judith P., Stade, Barbara G., Holzmann, Bernhard, Schwäble, Wilhelm, Riethmüller, Gert

    “…The 89-kDa cell surface glycoprotein, P3.58, is detectable on advanced human melanomas in situ but not on benign melanocytes or early melanomas. cDNA cloning…”
    Get full text
    Journal Article
  9. 9

    Structural characteristics of the 5' region of the human ICAM-1 gene by Stade, B G, Messer, G, Riethmüller, G, Johnson, J P

    Published in Immunobiology (1979) (01-12-1990)
    “…The ICAM-1 glycoprotein, one of the major cellular adhesion molecules, exhibits a diverse and highly regulated tissue distribution. To better understand the…”
    Get more information
    Journal Article
  10. 10
  11. 11

    The melanoma progression-associated antigen P3.58 is identical to the intercellular adhesion molecule, ICAM-1 by Johnson, J P, Stade, B G, Hupke, U, Holzmann, B, Riethmüller, G

    Published in Immunobiology (1979) (01-12-1988)
    “…The 89kd cell surface glycoprotein, P3.58, is expressed on human malignant melanomas in situ where it is associated with an increased risk of metastatic…”
    Get more information
    Journal Article